Holding types
Countries
Sectors
Analyst ratings
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDNA: Healthcare Dashboard For February
IDNA
Seeking Alpha18 February 2024
This article provides a monthly dashboard with aggregate industry metrics in the healthcare sector. Fast facts on IDNA, a thematic and volatile biotech ETF. We conclude with 10 healthcare stocks cheaper than their peers in February.
IDNA: Continues To Underperform, But With Long-Term Potential
IDNA
Seeking Alpha08 June 2023
I rate IDNA a Hold due to its focus on biotech stocks with long-term growth potential in a rapidly growing healthcare industry. Despite impressive growth since its inception in 2019, IDNA has experienced a downward trajectory since 2021, with its current price lower than at inception. The healthcare industry is predicted to be the fastest growing industry in the US in 2023, with a 15% growth rate expected by 2027, making it a profitable long-term investment space.
FAQ
- What is IDNA ETF?
- Does IDNA pay dividends?
- What stocks are in IDNA ETF?
- What is the current assets under management for IDNA?
- What is IDNA average volume?
- What is IDNA expense ratio?
- What is IDNA inception date?
What is IDNA ETF?
IDNA ETF is an exchange-traded fund that focuses on companies involved in innovative technologies and digital assets. It aims to provide investors with exposure to the growth potential of the digital economy while offering diversification and liquidity typical of ETFs.
Does IDNA pay dividends?
Yes, the iShares Genomics Immunology and Healthcare ETF does pays dividends, with
the most recent payment being
$0.11
per share. The last ex-dividend date was on 11 June 2024, and the next ex-dividend date has not been announced yet
What stocks are in IDNA ETF?
As of today, iShares Genomics Immunology and Healthcare ETF inlcudes 62 holdings, with 37 of them being companies from 11 different countries and 1 sectors. The most weighted holdings are Exelixis (6.52%), Revolution Medicines (5.77%) and Gilead Sciences (5.67%)
What is the current assets under management for IDNA?
Assets under management of iShares Genomics Immunology and Healthcare ETF is $139 M
What is IDNA average volume?
Average volume of iShares Genomics Immunology and Healthcare ETF is $27 K
What is IDNA expense ratio?
Expense ratio of iShares Genomics Immunology and Healthcare ETF is 0.47%
What is IDNA inception date?
Inception date of iShares Genomics Immunology and Healthcare ETF is 14 June 2019